Related references
Note: Only part of the references are listed.Sclerostin and bone strength in women in their 10th decade of life
Sara Thorson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
Christine Hamann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
An overview of the regulation of bone remodelling at the cellular level
Jasreen Kular et al.
CLINICAL BIOCHEMISTRY (2012)
Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training
Reina Armamento-Villareal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Serum Sclerostin Increases in Healthy Adult Men during Bed Rest
J. M. Spatz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sclerostin and Its Association with Physical Activity, Age, Gender, Body Composition, and Bone Mineral Content in Healthy Adults
Karin Amrein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Physical Activity in Relation to Serum Sclerostin, Insulin-Like Growth Factor-1, and Bone Turnover Markers in Healthy Premenopausal Women: A Cross-Sectional and a Longitudinal Study
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A sclerostin-based theory for strain-induced bone formation
Rene F. M. van Oers et al.
BIOMECHANICS AND MODELING IN MECHANOBIOLOGY (2011)
Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes
T. Neumann et al.
DIABETIC MEDICINE (2011)
Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism
Gerald J. Atkins et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Amazing Osteocyte
Lynda F. Bonewald
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Bone: from a reservoir of minerals to a regulator of energy metabolism
Cyrille B. Confavreux
KIDNEY INTERNATIONAL (2011)
Osteoporosis: now and the future
Tilman D. Rachner et al.
LANCET (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
Sclerostin: Current Knowledge and Future Perspectives
M. J. C. Moester et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Faryal S. Mirza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
Agostino Gaudio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Bone Metabolic Abnormalities Associated with Well-Controlled Type 1 Diabetes (IDDM) in Young Adult Women: A Disease Complication Often Ignored or Neglected
Priscilla G. Masse et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2010)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Charles A. O'Brien et al.
PLOS ONE (2008)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Bone formation is impaired in a model of type 1 diabetes
KM Thrailkill et al.
DIABETES (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Wnt signaling in osteoblasts and bone diseases
JJ Westendorf et al.
GENE (2004)
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women
KK Nicodemus et al.
DIABETES CARE (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
